
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of lipid metabolism on cuproptosis-inducing cancer therapy
Yue Zhong, Wei Zeng, Yongbo Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116247-116247
Open Access | Times Cited: 9
Yue Zhong, Wei Zeng, Yongbo Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116247-116247
Open Access | Times Cited: 9
Showing 9 citing articles:
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Exploring cell death pathways in oral cancer: mechanisms, therapeutic strategies, and future perspectives
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Relationship between the level of mixed chemicals in male urine and the prevalence of male cancers, especially prostate cancer
Bin Zhang, Hao Sun, Bin Zhu, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Bin Zhang, Hao Sun, Bin Zhu, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancer
Cheng Zeng, Chang Xu, Shuning Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cheng Zeng, Chang Xu, Shuning Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
FDX1 promotes elesclomol-induced PANoptosis in diffuse large B-cell lymphoma via activating IRF3/IFN-β signaling
Wei‐Feng Chen, Yuhang Jiang, Jun Zeng, et al.
Oncogene (2025)
Closed Access
Wei‐Feng Chen, Yuhang Jiang, Jun Zeng, et al.
Oncogene (2025)
Closed Access
Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease
Wangjing Tan, Junli Zhang, Li Chen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4830-4845
Open Access | Times Cited: 2
Wangjing Tan, Junli Zhang, Li Chen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4830-4845
Open Access | Times Cited: 2
Multi-omic validation of the cuproptosis-sphingolipid metabolism network: modulating the immune landscape in osteosarcoma
Qingbiao Li, Jiarui Fang, Kai Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Qingbiao Li, Jiarui Fang, Kai Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis
Kaixuan Du, Yongbo Luo, Lei Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 40, pp. 2971-2985
Closed Access | Times Cited: 1
Kaixuan Du, Yongbo Luo, Lei Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 40, pp. 2971-2985
Closed Access | Times Cited: 1
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology
Limei Zhang, Aihui Xie, Jinghxian Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189180-189180
Closed Access | Times Cited: 1
Limei Zhang, Aihui Xie, Jinghxian Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189180-189180
Closed Access | Times Cited: 1
Cuproptosis: an emerging domain for copper-based nanomaterials mediated cancer therapy
Fan Zhao, Zhuangzhuang Zhao, Hao Gao, et al.
MedMat. (2024) Vol. 1, Iss. 2, pp. 74-94
Closed Access
Fan Zhao, Zhuangzhuang Zhao, Hao Gao, et al.
MedMat. (2024) Vol. 1, Iss. 2, pp. 74-94
Closed Access